Publications

Publications

Filter Results: (6,517) Arrow Down
Filter Results: (6,517) Arrow Down Arrow Up

Show Results For

Show Results For

← Page 74 of 6,517 Results →
  • 25 Sep 2000
  • Research & Ideas

More Than the Sum of Its Parts: The Impact of Modularity on the Computer Industry

rules, module designers still have a lot of choices. Their alternative designs will normally display different performance characteristics that customers care about. In a modular system, those alternatives can be mixed and matched. The... View Details
Keywords: by Staff; Computer; Consumer Products; Technology
  • October 2013 (Revised January 2015)
  • Case

The Slingshot: Improving Water Access

By: John A. Quelch, Margaret L. Rodriguez and Carin-Isabel Knoop
In 2012, over 750 million people around the globe lacked access to safe drinking water. Dean Kamen, inventor of the Segway, sought to bring fresh water to poor and rural areas with the Slingshot, a water purification device. Kamen's challenge was to identify ways to... View Details
Keywords: Water; Public Health; Health Care; Slingshot; Dean Kamen; DEKA; Coca-Cola; Developing Markets; Freestyle; Safety; Natural Environment; Pollutants; Health; Distribution Channels; Developing Countries and Economies; Innovation and Invention; Africa; Latin America; South America; Asia
Related
  • 2016
  • Book

Consumers, Corporations, and Public Health: A Case-Based Approach to Sustainable Business

By: John A. Quelch
The public health footprint associated with corporate behavior has come under increased scrutiny in the last decade, with an increased expectation that private profit not come at the expense of consumer welfare.

Consumers, Corporations, and Public... View Details
Keywords: Consumer; Corporate Culture; Public Health; Consumer Behavior; Marketing Strategy; Corporate Strategy; Health; Innovation and Invention; Innovation and Management; Supply Chain Management; Advertising Industry; Advertising Industry; Advertising Industry; Advertising Industry; Advertising Industry; Advertising Industry; Advertising Industry; Advertising Industry; Advertising Industry; Advertising Industry; Advertising Industry; Advertising Industry; Advertising Industry; Advertising Industry; Advertising Industry; Advertising Industry; Advertising Industry; Advertising Industry; Advertising Industry; Advertising Industry; Advertising Industry; Asia; Oceania; North and Central America; Middle East; Latin America; Europe
Related
  • August 2018
  • Article

The Impact of the Entry of Biosimilars: Evidence from Europe

By: Fiona M. Scott Morton, Ariel Dora Stern and Scott Stern
Biologics represent a substantial and growing share of the U.S. drug market. Traditional “small molecule” generics quickly erode the price and share of the branded product upon entry; however, only a few biosimilars have been approved in the U.S. since 2015, thereby... View Details
Keywords: Health Care; Biosimilars; Biologics; Pharmaceutical Competition; Healthcare Spending; Innovation; Health Care and Treatment; Spending; Market Entry and Exit; Competition; Innovation and Invention; Pharmaceutical Industry; United States; Europe
Related
  • July 1997
  • Article

Market-Driven Health Care: What It Means to You

By: Regina E. Herzlinger
Keywords: Markets; Health Care and Treatment; Health Industry
Related
  • 16 May 2017
  • Blog Post

Making the Move into Digital Health and Software Engineering

We caught up with Andrea Coravos (HBS 2017) after a Q&A she did with the MBA Voices blog during her second year at HBS. Coravos reflects on her time at HBS and how she transitioned into digital health and engineering following a... View Details
Keywords: Health Care; Health Care
  • June 2024
  • Article

Valuing the Societal Impact of Medicines and Other Health Technologies: A User Guide to Current Best Practices

By: Jason Shafrin, Jaehong Kim, Joshua T. Cohen, Louis P. Garrison, Dana A. Goldman, Jalpa A. Doshi, Joshua Krieger, Darius N. Lakdawalla, Peter J. Neumann, Charles E. Phelps, Melanie D. Whittington and Richard Willke
This study argues that value assessment conducted from a societal perspective should rely on the Generalized Cost-Effectiveness Analysis (GCEA) framework proposed herein. Recently developed value assessment inventories—such as the Second Panel on Cost-Effectiveness’s... View Details
Keywords: Health Care and Treatment; Valuation; Cost vs Benefits; Society
Related
  • Article

Regulating Hospital Prices Based on Market Concentration Is Likely to Leave High-Price Hospitals Unaffected

By: Maximilian J. Pany, Michael E. Chernew and Leemore S. Dafny
Concern about high hospital prices for commercially insured patients has motivated several proposals to regulate these prices. Such proposals often limit regulations to highly concentrated hospital markets. Using a large sample of 2017 US commercial insurance claims,... View Details
Keywords: Health Care Providers; Hospitals; Insurance Market Regulation; Price Regulation; Markets; Health Care and Treatment; Cost; Quality; Insurance; Price; Governing Rules, Regulations, and Reforms
Related
  • March 2010
  • Teaching Note

Narayana Hrudayalaya Heart Hospital: Cardiac Care for the Poor (TN)

By: Tarun Khanna and V. Kasturi Rangan
Teaching Note for [505078]. View Details
Keywords: Health Industry; Health Industry; Bangalore
Related
  • 12 Oct 2015
  • News

Google Ventures: Big-time Consumer Health Is Still a Dream

Keywords: Ambulatory Health Care Services; Ambulatory Health Care Services
  • May 2013
  • Article

Health Care's Service Fanatics: How the Cleveland Clinic Leaped to the Top of the Patient-satisfaction Surveys

By: James Merlino and Ananth Raman
The Cleveland Clinic has long had a reputation for medical excellence. But in 2009 the CEO acknowledged that patients did not think much of their experience there, and he decided to act. Since then the Clinic has leaped to the top tier of patient-satisfaction surveys,... View Details
Keywords: Health Care and Treatment; Customer Satisfaction; Health Industry; Cleveland
Related
  • September 2023
  • Teaching Note

Fighting the Battle of the Bulge—Evaluating Do Good/Do Well Innovations in Morbid Obesity Treatment

By: Regina E. Herzlinger
Teaching Note for HBS Case No. 304-009. The case is part of the first module of the Innovating in Health Care course. Its purpose is to demonstrate how to evaluate the “do good” and do well” potential of a health care innovation. View Details
Keywords: Innovation In Healthcare Delivery; Innovation; Obesity; Digital Health; Weight Loss; Health Care and Treatment; Innovation and Management; Business Model; Medical Specialties; Mission and Purpose; Health Industry
Related
  • Research Summary

Clinical Trials as a setting for Health Policy and Management Research

The clinical trial marketplace is in flux. A decade ago, pharmaceutical firms almost exclusively conducted the study of their novel drug compounds within major academic medical centers. But today, industry-sponsored clinical trials are increasingly using community... View Details
  • September 2014 (Revised February 2015)
  • Case

Pfizer and AstraZeneca: Marketing an Acquisition (A)

By: John A. Quelch and James Weber
In 2014, Pfizer proposed a friendly acquisition of AstraZeneca, but the AstraZeneca board resisted over price and strategy concerns. Was this good for pharmaceutical consumers? Pfizer, like pharmaceutical companies in general, faced difficulties in growing sales due to... View Details
Keywords: Health Care Policy; Mergers And Acquisitions; Marketing; Government Relations; Crisis Management; Decision Making; Growth and Development; Management; Markets; Strategy; Pharmaceutical Industry; United Kingdom; United States
Related
  • Web

Health Plans - Institute For Strategy And Competitiveness

HBS ISC Health Care Health Care Value-Based Health Care View Details
  • September 2014
  • Supplement

Pfizer and AstraZeneca: Marketing an Acquisition (B)

By: John A. Quelch and James Weber
This (B) case provides a brief description of the outcome of the (A) case. View Details
Keywords: Health Care Policy; Pharmaceutical Sales; Mergers And Acquisitions; Marketing; Pharmaceutical Industry; United Kingdom; United States
Related
  • 2012
  • Report

Competing by Saving Lives: How Pharmaceutical and Medical Device Companies Create Shared Value in Global Health

By: Mark R. Kramer, Kyle Peterson, Matthew Rehrig, Mike Stamp and Samuel Kim
Examples of how pharmaceutical and medical companies are addressing unmet health needs in low- and middle- income economies, creating shared value by providing products and services that tackle global health problems. View Details
Keywords: Shared Value; Low- And Middle-income Economies; Health Care and Treatment; Global Range; Pharmaceutical Industry; Pharmaceutical Industry
Related
  • 23 Jun 2016
  • News

Making better decisions when it comes to your health

  • Article

Overturning the ACA's Medicaid Expansion Would Likely Decrease Low-Income, Reproductive-Age Women's Healthcare Spending and Utilization

By: Lucy Chen, Richard G. Frank and Haiden A. Huskamp
In late 2020, the Supreme Court began hearing a case challenging the Affordable Care Act (ACA), which led to coverage gains for many low-income, reproductive-age women. To explore potential implications of a full ACA repeal for this population, we examined gains... View Details
Keywords: Medicaid; Women's Health; Health Insurance; Health Care and Treatment; Gender; Insurance; Poverty; Health Industry; United States
Related
  • Research Summary

Overview

Phil's work aims to identify the drivers of performance for healthcare organizations and providers, and the mechanisms by which this performance can change over time. In complex healthcare settings, the optimal choice of treatment can be highly ambiguous. As a... View Details
Keywords: Primary Care; Medical Decision-making; Learning By Doing; Healthcare Organizations; Healthcare Operations; Health Economics